These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 13769974)

  • 1. [On the adrenergic action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    C R Hebd Seances Acad Sci; 1961 Apr; 252():2616-8. PubMed ID: 13769974
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiological significance of monoamine oxidase.
    IMAIZUMI R; OMORI K; UNOKI A; SANO K; WATARI Y; NAMBA J; INUI K
    Jpn J Pharmacol; 1959 Mar; 8():87-95. PubMed ID: 13852733
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the active center of monoamine oxidase.
    ZELLER EA
    Experientia; 1960 Sep; 16():399-402. PubMed ID: 13788171
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 7. [On quantitative differences in the effect between 1-isonicotinoyl-2-isopropyl hydrazine (iproniazid) and isopropyl hydrazine on monoamine oxidase].
    HEIM F; DIEMER K
    Med Exp Int J Exp Med; 1960; 3():249-51. PubMed ID: 13712856
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurophysiological studies with monoamine oxidase inhibitors.
    SCHALLEK W
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():64-6. PubMed ID: 14442400
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of trans-2-phenylcycloproplylamine upon norepinephrine concentration and monamine oxidase activity of rat brain.
    GREEN H; ERICKSON RW
    J Pharmacol Exp Ther; 1960 Jul; 129():237-42. PubMed ID: 13851486
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
    HESS SM; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
    [No Abstract]   [Full Text] [Related]  

  • 11. [Iproniazid and other inhibitors of monoamine oxidase in the treatment of angina pectoris].
    ABAZA A; RUTLISBERGER PA
    Presse Med (1893); 1960 May; 68():1049-52. PubMed ID: 13791366
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurochemical correlates of behavior II. Correlation of brain monoamine oxidase activity with behavioural changes after iproniazid and 5-hydroxytryptophan administration.
    APRISON MH; FERSTER CB
    J Neurochem; 1961 Mar; 6():350-7. PubMed ID: 13683915
    [No Abstract]   [Full Text] [Related]  

  • 13. Amine oxidases. XIX. Inhibition of monoamine oxidase by phenylcyclopropylamines and iproniazid.
    ZELLER EA; SARKAR S
    J Biol Chem; 1962 Jul; 237():2333-6. PubMed ID: 14010087
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our experiences with monoamine oxidase inhibiting substances].
    TAUBER CG
    Psychiatr Neurol (Basel); 1960 Jul; 140():148-51. PubMed ID: 13775480
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of the irreversible inhibition of rat-liver monoamine oxidase by iproniazid (marsilid).
    DAVISON AN
    Biochem J; 1957 Oct; 67(2):316-22. PubMed ID: 13471553
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of monoamine oxidase inhibitory effects of iproniazid and its phenyl congener.
    HORITA A; PARKER RG
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):617-9. PubMed ID: 13614441
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of iproniazid on monoamines and monamine oxidase in human brain.
    GANROT PO; ROSENGREN E; GOTTFRIES CG
    Experientia; 1962 Jun; 18():260-1. PubMed ID: 13896669
    [No Abstract]   [Full Text] [Related]  

  • 18. [Apropos of the mechanism of action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    Experientia; 1961 Dec; 17():563-4. PubMed ID: 14473094
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of nialamide on coronary circulation. The influence exerted by a serotonin antagonist on the action of nialamide and of iproniazid].
    GAVEND M; GAVEND MR; MERCIER J
    C R Seances Soc Biol Fil; 1960; 154():2089-92. PubMed ID: 24545639
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of diamine oxidase in vivo by hydrazine derivatives.
    BURKARD WP; GEY KF; PLETSCHER A
    Biochem Pharmacol; 1960 Jul; 3():249-55. PubMed ID: 13806127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.